By Counterforce Health Team in Defitelio (defibrotide) —

How to Get Defitelio (Defibrotide) Covered by Cigna in Ohio: Appeals Process and State Review Rights

Answer Box: Getting Defitelio Covered by Cigna in Ohio

Defitelio (defibrotide) requires prior authorization from Cigna for hepatic veno-occlusive disease with renal/pulmonary dysfunction post-HSCT. Your physician calls 1-800-882-4462 or submits via ExpressPAth for 24-72 hour review. If denied, you have 180 days to file internal appeals with Cigna, then external review through Ohio's Department of Insurance. Ohio residents get independent medical review via certified IROs, with expedited options for urgent cases. Start today: Have your transplant team call Cigna's PA line with your HSCT history and VOD severity documentation.

Table of Contents

  1. Why Ohio State Rules Matter for Cigna Coverage
  2. Turnaround Standards and Timelines
  3. Step Therapy and Medical Exception Protections
  4. Continuity of Care During Plan Transitions
  5. External Review and Complaint Process
  6. Practical Scripts and Sample Language
  7. ERISA Plan Differences and Limitations
  8. Quick Reference Contacts
  9. FAQ

Why Ohio State Rules Matter for Cigna Coverage

Ohio's insurance regulations create important protections for Cigna members seeking coverage for specialty drugs like Defitelio. Under Ohio Revised Code Chapter 3922, you're entitled to specific appeal timelines and external review rights that can overturn Cigna's initial denials.

Coverage at a Glance for Defitelio

Requirement What It Means Where to Find It Source
Prior Authorization Required for all uses Call 1-800-882-4462 Cigna PA Process
Indication Hepatic VOD/SOS with renal or pulmonary dysfunction post-HSCT FDA-approved only FDA Label
Site of Care Inpatient hospital setting Buy-and-bill drug Jazz Pharmaceuticals
Appeal Deadline 180 days from final denial Internal then external Ohio External Review

Cigna processes most specialty drug requests through Express Scripts and Accredo. This means your appeal may involve multiple entities, but Ohio's consumer protections apply to the final coverage decision regardless of which pharmacy benefit manager handles the review.

Note: Self-funded employer plans follow federal ERISA rules instead of Ohio state protections. Check your Summary Plan Description to confirm which appeals process applies.

Turnaround Standards and Timelines

Cigna must respond to Defitelio prior authorization requests within specific timeframes under Ohio law:

Standard Review Timeline:

  • 72 hours for routine PA requests
  • 24 hours for expedited/urgent requests
  • 2 business days maximum per some Cigna policies

When to Request Expedited Review:

  • Active hepatic VOD with worsening symptoms
  • Patient already hospitalized for HSCT complications
  • Physician certifies delay would jeopardize health

Your transplant team can call 1-800-882-4462 and specifically request expedited review, providing clinical justification for the urgency. Document this request in your medical record.

Step Therapy and Medical Exception Protections

Ohio law provides protections when Cigna requires you to try other treatments before approving Defitelio. You can request a step therapy exception if:

  • Prior formulary drug is expected to be ineffective based on clinical history
  • Prior drug caused or is likely to cause adverse reaction or harm
  • Patient has tried the preferred drug previously with inadequate response
  • Preferred drug is contraindicated due to comorbid conditions

Medical Exception Documentation: Your physician should include in the appeal:

  • Specific reason the preferred treatment won't work
  • Clinical evidence supporting Defitelio as medically necessary
  • Timeline showing urgency (VOD progression can be rapid)
  • Reference to FDA orphan drug designation for severe hepatic VOD

Continuity of Care During Plan Transitions

If you're switching to or from Cigna while receiving post-HSCT care, Ohio provides continuity protections under Ohio Administrative Code 5160-26 for Medicaid managed care plans.

Protected Services Include:

  • Ongoing specialty medications from prior authorization
  • Established relationships with transplant specialists
  • Post-HSCT monitoring and follow-up care
  • Previously approved durable medical equipment

Submit your treatment plan and prior authorization documentation promptly when enrolling. The new plan must review and authorize equivalent coverage if medically justified.

External Review and Complaint Process

When Cigna denies Defitelio coverage after internal appeals, Ohio residents can request external review through independent medical experts.

Step-by-Step External Review Process:

  1. Exhaust Internal Appeals First
    • File written appeal with Cigna within 180 days
    • Include new clinical documentation
    • Request expedited review if urgent
  2. Submit External Review Request
  3. Independent Review Organization (IRO) Assignment
    • Ohio DOI randomly assigns qualified IRO
    • Submit additional documentation within 10 business days
    • IRO has medical expertise in transplant/oncology
  4. Binding Decision
    • 30 days for standard review
    • 72 hours for expedited urgent cases
    • Decision is binding on Cigna
Tip: Register for OH|ID at insurance.ohio.gov to track your external review case online through Ohio's External Review System.

Practical Scripts and Sample Language

Patient Phone Script for Cigna: "I'm calling about prior authorization for Defitelio, generic name defibrotide, for treatment of hepatic veno-occlusive disease following my hematopoietic stem cell transplant. My physician needs to submit clinical documentation showing I meet FDA criteria for severe VOD with renal or pulmonary dysfunction. Can you confirm the fastest submission method and provide the case reference number?"

Clinic Staff Script for Peer-to-Peer: "We're requesting peer-to-peer review for Defitelio coverage. The patient has confirmed severe hepatic VOD post-HSCT with [specify renal/pulmonary symptoms]. This is FDA-approved indication, not off-label use. The transplant physician is available for clinical discussion within 24 hours given the urgent nature."

Medical Necessity Letter Key Points:

  • Confirmed diagnosis: Hepatic VOD/SOS post-HSCT
  • Severity markers: Specify renal/pulmonary dysfunction
  • FDA indication match: Not prophylactic use
  • Clinical urgency: VOD progression timeline
  • Alternative treatments: Why supportive care insufficient

ERISA Plan Differences and Limitations

Many Ohio residents have health insurance through large employers that use self-funded ERISA plans. These plans are exempt from Ohio's state external review process and instead follow federal appeals procedures.

Key ERISA Differences:

  • Federal external review process applies (not Ohio's)
  • Different timeline: 4 months to request external review
  • Appeal directly to plan, not Ohio Department of Insurance
  • No state regulator oversight of the appeals process

Check your Summary Plan Description or call Cigna member services to confirm whether your plan is subject to ERISA or Ohio state regulation. Counterforce Health specializes in navigating these complex jurisdictional differences for specialty drug appeals.

Quick Reference Contacts

Cigna Prior Authorization:

  • Phone: 1-800-882-4462
  • ExpressPAth portal for providers
  • Accredo specialty pharmacy coordination

Ohio Department of Insurance:

Additional Support:

  • UHCAN Ohio (consumer advocacy)
  • Ohio Senior Health Insurance Information Program (OSHIIP) for Medicare questions
  • Jazz Pharmaceuticals patient support programs

FAQ

How long does Cigna PA take for Defitelio in Ohio? Standard review is completed within 72 hours. Expedited review for urgent cases is completed within 24 hours when physician certifies medical urgency.

What if Defitelio is not on Cigna's formulary? You can request a formulary exception by having your physician submit clinical rationale explaining why preferred alternatives are inappropriate for your specific case.

Can I request expedited appeal if my condition is worsening? Yes. Ohio law allows expedited external review (72 hours) when delay would seriously jeopardize health. Your transplant physician must certify the urgency.

Does step therapy apply if I failed other treatments outside Ohio? Medical records from any state showing prior treatment failures can support a step therapy exception request. Include documentation of inadequate response or adverse effects.

What happens if Cigna doesn't respond within the timeline? Failure to respond within required timeframes can be grounds for automatic approval or expedited appeal. Contact Ohio DOI if Cigna misses deadlines.

Are there patient assistance programs for Defitelio? Jazz Pharmaceuticals offers patient support services. Contact them directly as manufacturer programs can help with copays and access while appeals are pending.

Can I continue current treatment during the appeal? Ohio's continuity of care protections may apply if you're transitioning plans. For ongoing treatment during appeals, discuss bridge therapy options with your transplant team.

When should I involve the Ohio Department of Insurance? Contact ODI if Cigna denies your request for external review, misses appeal deadlines, or you need help understanding your rights under Ohio law.

About Counterforce Health Counterforce Health helps patients and clinicians navigate complex specialty drug appeals by analyzing denial letters, plan policies, and clinical notes to create targeted, evidence-backed appeals. Their platform identifies the specific denial basis and drafts point-by-point rebuttals aligned to each plan's own rules, pulling the right medical citations and weaving them into appeals that meet procedural requirements while tracking deadlines.

Sources & Further Reading

This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan documents for guidance specific to your situation. For questions about Ohio insurance regulations, contact the Ohio Department of Insurance at 1-800-686-1526.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.